Iron Oxide Nanoparticle Hyperthermia Heating
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Magnetic nanoparticle hyperthermia for cancer therapy faces limitations due to technical challenges in selectively delivering heat to target tissues without overheating adjacent normal tissue, primarily due to non-specific Joule heating caused by alternating magnetic fields.
Innovation Solution
Development of surfactant-coated iron oxide nanoparticles produced through high-gravity controlled precipitation, which exhibit enhanced heating capabilities at clinically relevant amplitudes and frequencies, allowing for selective heat delivery to cancer tissues while maintaining safety by minimizing non-specific heating.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Temperature
If alternating magnetic fields are applied to heat magnetic nanoparticles for cancer therapy, then heating capability is improved, but non-specific Joule heating of surrounding tissue increases
Solution Approach 1:
The patent applies local quality by engineering nanoparticles with specific magnetic properties (high saturation magnetization, appropriate anisotropy) that concentrate heating effects locally at the nanoparticle level rather than distributing energy broadly through tissue. The surfactant coating and controlled size distribution ensure that heating is localized to regions containing the nanoparticles, minimizing non-specific Joule heating in surrounding healthy tissue.
Solution Approach 2:
The patent employs parameter changes by optimizing multiple nanoparticle characteristics including magnetic moment, particle size (5-100 nm), composition ratios (Fe3O4 and γ-Fe2O3 phases), and surfactant coating properties. These parameter optimizations enable the nanoparticles to achieve high heating efficiency at lower AMF amplitudes, thereby reducing the overall energy input required and minimizing non-specific tissue heating.
2Temperature
If high AMF amplitude is used to achieve therapeutic heating, then heating effectiveness is improved, but safety margins are reduced due to potential overheating of normal tissue
Solution Approach 1:
The patent utilizes parameter changes by developing nanoparticles with optimized magnetic properties including high saturation magnetization and controlled anisotropy energy. The specific composition (76% Fe3O4 and 24% γ-Fe2O3) and size distribution (5-100 nm) enable the particles to generate sufficient heat at lower AMF amplitudes, maintaining safety margins while achieving therapeutic effectiveness. The surfactant coating further modulates the magnetic response to optimize heating efficiency.
3Temperature
If nanoparticle concentration is increased to enhance heating, then therapeutic effect is improved, but non-specific heating of surrounding tissue increases
Solution Approach 1:
The patent applies local quality by ensuring that heating effects are concentrated at the nanoparticle locations through optimized magnetic properties. The surfactant-coated nanoparticles with controlled size and composition generate heat locally through magnetic relaxation mechanisms, allowing therapeutic effects at lower concentrations while minimizing non-specific heating in tissue regions with lower nanoparticle density.
4Object-affected harmful factors
If low AMF frequency is used to minimize non-specific heating, then safety is improved, but heating efficiency of nanoparticles is reduced
Solution Approach 1:
The patent employs parameter changes by optimizing the magnetic properties of nanoparticles including saturation magnetization, anisotropy energy, and relaxation times. These optimized parameters enable efficient heating at lower AMF frequencies by enhancing magnetic relaxation mechanisms (Néel and Brownian relaxation), allowing the nanoparticles to compensate for the reduced driving frequency while minimizing non-specific tissue heating.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nanoparticles demonstrate substantial heating capabilities at low field amplitudes, achieving a therapeutically effective temperature rise in cancer tissues while keeping surrounding tissue temperatures within physiological ranges, as evidenced by in-vitro and in-vivo experiments.
Implementation Method 1
non-specific Joule heat is deposited into the tissue due to eddy currents
Implementation Method 2
non-specific Joule heat is deposited into the tissue due to eddy currents
Implementation Method 3
magnetic nanoparticle heating depends upon both AMF frequency and amplitude
Data Source
AI summary
Iron oxide nanoparticle compositions, methods of preparing the nanoparticles using high gravity controlled precipitation (HGCP), and methods of using the nanoparticles are disclosed.